Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

Expression of p16INK4A in gastrointestinal stromal tumours (GISTs): two different forms exist that independently correlate with poor prognosis.

Haller F, Agaimy A, Cameron S, Beyer M, Gunawan B, Happel N, Langer C, Ramadori G, von Heydebreck A, Füzesi L.

Histopathology. 2010 Feb;56(3):305-18. doi: 10.1111/j.1365-2559.2010.03478.x.

PMID:
20459531
2.

Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).

Haller F, Löbke C, Ruschhaupt M, Cameron S, Schulten HJ, Schwager S, von Heydebreck A, Gunawan B, Langer C, Ramadori G, Sültmann H, Poustka A, Korf U, Füzesi L.

J Pathol. 2008 Jul;215(3):253-62. doi: 10.1002/path.2352.

PMID:
18438954
3.

Heat shock protein 90 overexpression independently predicts inferior disease-free survival with differential expression of the alpha and beta isoforms in gastrointestinal stromal tumors.

Li CF, Huang WW, Wu JM, Yu SC, Hu TH, Uen YH, Tian YF, Lin CN, Lu D, Fang FM, Huang HY.

Clin Cancer Res. 2008 Dec 1;14(23):7822-31. doi: 10.1158/1078-0432.CCR-08-1369.

4.

Immunohistochemical expression of p16INK4A, Ki-67, and Mcm2 proteins in gastrointestinal stromal tumors: prognostic implications and correlations with risk stratification of NIH consensus criteria.

Huang HY, Huang WW, Lin CN, Eng HL, Li SH, Li CF, Lu D, Yu SC, Hsiung CY.

Ann Surg Oncol. 2006 Dec;13(12):1633-44. Epub 2006 Sep 30.

PMID:
17013685
5.

Ezrin overexpression in gastrointestinal stromal tumors: an independent adverse prognosticator associated with the non-gastric location.

Wei YC, Li CF, Yu SC, Chou FF, Fang FM, Eng HL, Uen YH, Tian YF, Wu JM, Li SH, Huang WW, Li WM, Huang HY.

Mod Pathol. 2009 Oct;22(10):1351-60. doi: 10.1038/modpathol.2009.107. Epub 2009 Jul 31.

6.

The abnormalities in the p53/p21WAF1 pathway have a significant role in the pathogenesis and progression of gastrointestinal stromal tumors.

Chou YP, Lin JW, Wang CC, Chiu YC, Huang CC, Chuah SK, Tai MH, Yi LN, Lee CM, Changchien CS, Hu TH.

Oncol Rep. 2008 Jan;19(1):49-56.

PMID:
18097575
7.

Epithelioid/mixed phenotype in gastrointestinal stromal tumors with KIT mutation from the stomach is associated with accelerated passage of late phases of the cell cycle and shorter disease-free survival.

Haller F, Cortis J, Helfrich J, Cameron S, Schüler P, Schwager S, Gunawan B, Füzesi L, Agaimy A.

Mod Pathol. 2011 Feb;24(2):248-55. doi: 10.1038/modpathol.2010.188. Epub 2010 Sep 10.

8.

Prognostic role of E2F1 and members of the CDKN2A network in gastrointestinal stromal tumors.

Haller F, Gunawan B, von Heydebreck A, Schwager S, Schulten HJ, Wolf-Salgó J, Langer C, Ramadori G, Sültmann H, Füzesi L.

Clin Cancer Res. 2005 Sep 15;11(18):6589-97.

9.
10.

Diagnostic and prognostic markers for gastrointestinal stromal tumors in Norway.

Steigen SE, Bjerkehagen B, Haugland HK, Nordrum IS, Løberg EM, Isaksen V, Eide TJ, Nielsen TO.

Mod Pathol. 2008 Jan;21(1):46-53. Epub 2007 Oct 5.

11.

Gastrointestinal stromal tumours (GISTs): a clinicopathological and molecular study of 66 cases.

Koay MH, Goh YW, Iacopetta B, Grieu F, Segal A, Sterrett GF, Platten M, Spagnolo DV.

Pathology. 2005 Feb;37(1):22-31.

PMID:
15875730
12.

HuR cytoplasmic expression is associated with increased cyclin A expression and inferior disease-free survival in patients with gastrointestinal stromal tumours (GISTs).

Wei YC, Chou FF, Li CF, Li WM, Chen YY, Lan J, Li SH, Fang FM, Hu TH, Yu SC, Eng HL, Uen YH, Tian YF, Wang JC, Huang HY.

Histopathology. 2013 Oct;63(4):445-54. doi: 10.1111/his.12148. Epub 2013 Jul 26.

PMID:
23889148
13.

Role for p16(INK4a) in progression of gastrointestinal stromal tumors of the stomach: alteration of p16(INK4a) network members.

Mitomi H, Fukui N, Kishimoto I, Tanabe S, Kikuchi S, Saito T, Hayashi T, Yao T.

Hum Pathol. 2011 Oct;42(10):1505-13. doi: 10.1016/j.humpath.2011.01.005. Epub 2011 Apr 14.

PMID:
21496871
14.

Expression level of the mitotic checkpoint protein and G2-M cell cycle regulators and prognosis in gastrointestinal stromal tumors in the stomach.

Fujita A, Yamamoto H, Imamura M, Nakamura N, Maehara Y, Tsuneyoshi M, Oda Y.

Virchows Arch. 2012 Feb;460(2):163-9. doi: 10.1007/s00428-011-1181-z. Epub 2011 Dec 22.

PMID:
22190007
15.

The expression and prognostic role of hepatoma-derived growth factor in colorectal stromal tumors.

Hu TH, Lin JW, Chen HH, Liu LF, Chuah SK, Tai MH.

Dis Colon Rectum. 2009 Feb;52(2):319-26. doi: 10.1007/DCR.0b013e31819d1666.

PMID:
19279430
16.

p16INK4a expression and clinicopathologic parameters in renal cell carcinoma.

Ikuerowo SO, Kuczyk MA, von Wasielewski R, Shittu OB, Jonas U, Machtens S, Serth J.

Eur Urol. 2007 Mar;51(3):732-7; discussion 738. Epub 2006 Aug 23.

PMID:
16949731
17.

Increased KIT signalling with up-regulation of cyclin D correlates to accelerated proliferation and shorter disease-free survival in gastrointestinal stromal tumours (GISTs) with KIT exon 11 deletions.

Haller F, Löbke C, Ruschhaupt M, Schulten HJ, Schwager S, Gunawan B, Armbrust T, Langer C, Ramadori G, Sültmann H, Poustka A, Korf U, Füzesi L.

J Pathol. 2008 Oct;216(2):225-35. doi: 10.1002/path.2402.

PMID:
18729075
18.
20.

Loss of p16 protein defines high-risk patients with gastrointestinal stromal tumors: a tissue microarray study.

Schneider-Stock R, Boltze C, Lasota J, Peters B, Corless CL, Ruemmele P, Terracciano L, Pross M, Insabato L, Di Vizio D, Iesalnieks I, Dirnhofer S, Hartmann A, Heinrich M, Miettinen M, Roessner A, Tornillo L.

Clin Cancer Res. 2005 Jan 15;11(2 Pt 1):638-45.

Supplemental Content

Support Center